Edwin P Rock

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. doi request reprint Assessing proarrhythmic potential of drugs when optimal studies are infeasible
    Edwin P Rock
    GlaxoSmithKline R and D, King of Prussia, PA 19406 0930, USA
    Am Heart J 157:827-36, 836.e1. 2009

Detail Information

Publications1

  1. doi request reprint Assessing proarrhythmic potential of drugs when optimal studies are infeasible
    Edwin P Rock
    GlaxoSmithKline R and D, King of Prussia, PA 19406 0930, USA
    Am Heart J 157:827-36, 836.e1. 2009
    ..In these instances, alternative approaches to QT risk assessment must be considered. This article presents points to consider for evaluation of QT risk when alternative approaches are needed...